Steve Kanes

Company: EmbarkNeuo

Job title: Chief Executive Officer

Seminars:

Employing a Biomarker-Driven Approach to Depression with Selection Based on Neuroendocrine Changes 1:30 pm

Showcasing a precision medicine study of ANC-501 for MDD Outlining the rationale for harnessing biomarker-driven stress hormone system disruptions Next steps for advancing the precision medicine study into phase 3 and beyondRead more

day: Track 2: Translational & Clinical